These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 8608636)

  • 1. Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD).
    Bouma G; Xia B; Crusius JB; Bioque G; Koutroubakis I; Von Blomberg BM; Meuwissen SG; Peña AS
    Clin Exp Immunol; 1996 Mar; 103(3):391-6. PubMed ID: 8608636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in tumour necrosis factor and adhesion molecule genes in patients with inflammatory bowel disease: associations with HLA-DR and -DQ alleles and subclinical markers.
    Hirv K; Seyfarth M; Uibo R; Kull K; Salupere R; Latza U; Rink L
    Scand J Gastroenterol; 1999 Oct; 34(10):1025-32. PubMed ID: 10563674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic heterogeneity within ulcerative colitis determined by an interleukin-1 receptor antagonist gene polymorphism and antineutrophil cytoplasmic antibodies.
    Papo M; Quer JC; Gutierrez C; Broch M; Casellas F; Pastor RM; Olona M; Richart C
    Eur J Gastroenterol Hepatol; 1999 Apr; 11(4):413-20. PubMed ID: 10321759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies.
    Koss K; Satsangi J; Fanning GC; Welsh KI; Jewell DP
    Genes Immun; 2000 Feb; 1(3):185-90. PubMed ID: 11196710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in Korean patients with inflammatory bowel disease].
    Kim TH; Kim BG; Shin HD; Kim JW; Kim CG; Kim JS; Jung HC; Song IS
    Korean J Gastroenterol; 2003 Nov; 42(5):377-86. PubMed ID: 14646574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease.
    Bouma G; Crusius JB; Oudkerk Pool M; Kolkman JJ; von Blomberg BM; Kostense PJ; Giphart MJ; Schreuder GM; Meuwissen SG; Peña AS
    Scand J Immunol; 1996 Apr; 43(4):456-63. PubMed ID: 8668926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polymorphism of the microsatellites and tumor necrosis factor genes in chronic inflammatory bowel diseases].
    Heresbach D; Ababou A; Bourienne A; Alizadeh M; Quelvennec E; Pagenault M; Dabadie A; Berre NH; Campion JP; Launois B; Gosselin M; Genetet B; Bretagne JF; Semana G
    Gastroenterol Clin Biol; 1997; 21(8-9):555-61. PubMed ID: 9587492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between a gene polymorphism of tumor necrosis factor and inflammatory bowel disease.
    Song Y; Wu KC; Zhang L; Hao ZM; Li HT; Zhang LX; Qiao TD; Li CN; Fan DM
    Chin J Dig Dis; 2005; 6(4):170-4. PubMed ID: 16246225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour necrosis factor-alpha (-308G/A) promoter polymorphism is associated with ulcerative colitis in Brazilian patients.
    Tavares M; de Lima C; Fernandes W; Martinelli V; de Lucena M; Lima F; Telles A; Brandão L; de Melo Júnior M
    Int J Immunogenet; 2016 Dec; 43(6):376-382. PubMed ID: 27528546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn's disease, respectively.
    Sashio H; Tamura K; Ito R; Yamamoto Y; Bamba H; Kosaka T; Fukui S; Sawada K; Fukuda Y; Tamura K; Satomi M; Shimoyama T; Furuyama J
    Immunogenetics; 2002 Mar; 53(12):1020-7. PubMed ID: 11904678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variants in TNF-alpha but not DLG5 are associated with inflammatory bowel disease in a large United Kingdom cohort.
    Tremelling M; Waller S; Bredin F; Greenfield S; Parkes M
    Inflamm Bowel Dis; 2006 Mar; 12(3):178-84. PubMed ID: 16534418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of polymorphisms of tumor necrosis factor-alpha and polymorphic xenobiotic metabolizing enzymes in inflammatory bowel disease: study from northern India.
    Mittal RD; Manchanda PK; Bid HK; Ghoshal UC
    J Gastroenterol Hepatol; 2007 Jun; 22(6):920-4. PubMed ID: 17565649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of T Helper 1 Cytokine Gene Single Nucleotide Polymorphisms with Ulcerative Colitis and Crohn's Disease.
    Ebrahimi Daryani N; Sadr M; Soltani S; Saghazadeh A; Moossavi S; Shahkarami S; Farhadi E; Rezaei N
    Dig Dis; 2019; 37(1):21-32. PubMed ID: 30134230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms of tumor necrosis factor-alpha but not MDR1 influence response to medical therapy in pediatric-onset inflammatory bowel disease.
    Cucchiara S; Latiano A; Palmieri O; Canani RB; D'Incà R; Guariso G; Vieni G; De Venuto D; Riegler G; De'Angelis GL; Guagnozzi D; Bascietto C; Miele E; Valvano MR; Bossa F; Annese V;
    J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):171-9. PubMed ID: 17255827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-857 polymorphism in Israeli Jewish patients with inflammatory bowel disease.
    Fidder HH; Heijmans R; Chowers Y; Bar-Meir S; Avidan B; Pena AS; Crusius JB
    Int J Immunogenet; 2006 Apr; 33(2):81-5. PubMed ID: 16611251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF-alpha gene polymorphisms in Iranian Azari Turkish patients with inflammatory bowel diseases.
    Bonyadi M; Abdolmohammadi R; Jahanafrooz Z; Somy MH; Khoshbaten M
    Saudi J Gastroenterol; 2014; 20(2):108-12. PubMed ID: 24705148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
    Cantor MJ; Nickerson P; Bernstein CN
    Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease.
    Vatay A; Bene L; Kovács A; Prohászka Z; Szalai C; Romics L; Fekete B; Karádi I; Füst G
    Immunogenetics; 2003 Jul; 55(4):247-52. PubMed ID: 12811429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of ICAM-1 gene polymorphism in immunologic subsets of inflammatory bowel disease.
    Yang H
    Exp Clin Immunogenet; 1997; 14(3):214-25. PubMed ID: 9493790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.